BIO has increased by over 240% in the past 30 days. Why are DeSci and AI-driven pharmaceuticals once again attracting high-risk capital?

Since May 2026, the market enthusiasm for the DeSci sector has begun to rebound, and BIO has become one of the projects with the fastest increase in volatility and discussion recently. Gate行情 data shows that BIO has gained over 240% in the past 30 days, even after the market entered a consolidation phase in mid-May, with BIO’s price remaining in a relatively high range. Based on current market feedback, this rally is no longer just driven by short-term sentiment, but is directly related to Bio Protocol’s recent continuous promotion of AI research-related products.

Unlike the previous AI hot spots, the current market is no longer just concerned with “whether AI can generate content,” but whether AI has begun to enter more realistic application scenarios. AI research, AI drug development, and on-chain data collaboration are thus gradually becoming new hot spots in the crypto market.

What new developments has Bio Protocol released recently

Since April 2026, Bio Protocol has significantly accelerated its product and ecosystem development pace, which is also one of the key reasons why BIO has recently regained market attention.

The project team has recently announced the PeptAI Ignition Sale, BioXP upgrade, and demos related to BIOS AI Scientist. Among them, the launch of PeptAI has attracted particular market attention because it attempts to further bring AI drug discovery into on-chain research narratives.

Compared to most previous DeSci projects still at the stage of research funding or community governance, Bio Protocol is gradually strengthening the connection between AI models, research data, and collaboration mechanisms. This indicates that the DeSci sector is evolving from “concept-driven” to “tool-driven.”

Deeper changes are that, after a year of large-scale expansion of Agent, automated trading, and AI Meme assets, the market has started to look for the next phase of AI directions with more realistic scenarios. AI research and AI drug development have just become new areas of renewed market focus.

To some extent, the recent rise of BIO essentially reflects the market’s re-pricing of the “AI + research” niche sector.

Why has market discussion of PeptAI increased significantly after its launch

After PeptAI’s launch, discussion of BIO on social media and trading platforms has noticeably increased.

Recently, the crypto market’s focus on AI concepts has mainly been on AI Agents, automated trading, and content generation. But as these sectors enter high-volatility phases, some market funds are starting to seek new AI hot spots.

PeptAI has attracted attention not only because it belongs to the AI concept but also because it combines multiple hot directions such as AI research, biological data, and on-chain collaboration. This means BIO now has strong cross-hotspot linkage capabilities.

Compared to traditional Layer 1 or transaction infrastructure narratives, AI research itself is easier to generate market discussion space because it not only involves AI concepts but also has long-term imagination in healthcare, scientific research, and future industries.

This reflects that current market hotspots are shifting from “high-frequency emotion-driven” to “realistic application-oriented” AI directions. Although AI research is still far from forming mature commercial models, the market has begun to pre-trade this expectation.

Which crypto sectors are beginning to spread the concept of AI drug development

The current spread of the AI drug development concept has already started to influence multiple crypto sub-sectors.

Previously, market attention on AI sectors mainly focused on traffic-driven products like AI Agents, trading tools, and content generation. But as the market enters a hot rotation phase, AI funds are seeking new narrative outlets, and DeSci provides a new expansion space.

From the current market structure, the AI research concept is gradually linking with data infrastructure, on-chain collaboration networks, and research incentive mechanisms. This indicates that the positioning of the DeSci sector is also changing.

In the past, the market tended to see DeSci as “research governance” or “research DAOs,” but now the focus is shifting to whether on-chain mechanisms can help improve data collaboration efficiency in AI research and whether they can form new organizational methods for research resources.

This is a very critical change because it means AI hotspots are moving from purely traffic logic to real application logic. AI research, AI data, and decentralized research collaboration are thus regaining market attention.

From the perspective of hotspot diffusion paths, signs show that the market is gradually spreading from AI trading and AI Agents to AI research directions, with BIO being part of this diffusion chain.

What short-term funds are paying attention to BIO

Based on recent market performance, the main investors attracted by BIO are still high-risk appetite short-term funds.

On one hand, BIO’s overall market cap is relatively limited, with large price fluctuation space, making it more susceptible to short-term sentiment. On the other hand, the DeSci sector has been relatively marginal for a long time, and when market hotspots reflow, small-cap assets tend to rebound with high volatility.

This means that the current BIO trend is largely the result of “hotspot rotation + high elasticity assets.”

Compared to traditional mainstream assets, such funds focus more on narrative dissemination speed, market discussion, and AI hotspot linkage ability rather than long-term cash flow logic. From current market feedback, some short-term traders are gradually expanding from traditional AI Agents to DeSci and AI research sectors.

This fund migration path essentially reflects that internal AI hotspots are beginning to experience new sub-rotation.

Meanwhile, BIO’s recent volatility expansion further reinforces the willingness of high-risk funds to participate. For short-term traders, high-volatility assets are inherently more likely to attract trading attention.

Changes in asset rotation within DeSci

Compared to 2024 and early 2025, the DeSci sector has already shown clear changes.

Previously, market attention to DeSci was mostly at the conceptual level, with most projects lacking continuous product actions and stable market heat, thus failing to form a genuine capital structure over the long term.

But since 2026, with the spread of AI research concepts, DeSci has regained new market discussion space.

This indicates that the market is reassessing whether “on-chain research collaboration” can form a new synergy with AI. Compared to the previous emphasis on research democratization, the current focus is more on whether AI can truly improve research efficiency and whether on-chain mechanisms can optimize data collaboration.

This is a very critical change because it signifies that DeSci is evolving from “idealized narratives” to “AI application extension directions.”

From the hotspot diffusion perspective, a new diffusion logic is forming: after AI trading and AI Agents, some funds are starting to seek more long-term promising AI application directions, with AI research becoming a new hot spot.

BIO’s current market enthusiasm is gradually forming in this context.

How market sentiment is changing under BIO’s high volatility

BIO’s recent high-volatility trend also reflects that current market sentiment is shifting toward high-risk assets.

After mainstream assets entered consolidation, some trading funds began to seek small-cap, highly elastic directions again, and the renewed activity of AI and DeSci narratives has provided new trading attention for BIO.

From current market feedback, BIO already shows clear sentiment-driven features. Social media discussions, AI hot spot diffusion, and changes in market risk appetite all significantly impact BIO’s short-term fluctuations.

Meanwhile, the market is also showing signs of “hotspot rapid switching.” Some high-volatility assets, after quick capital accumulation, tend to enter rapid oscillation phases. Therefore, although BIO still maintains high market heat, its trading structure remains mainly short-term.

What truly warrants attention is whether Bio Protocol can continue to sustain market discussion through product actions and ecosystem development. Without ongoing event-driven momentum, the current high-volatility state may gradually weaken.

Factors that may influence BIO’s future popularity

Whether BIO’s future popularity can be sustained mainly depends on several key variables.

First, whether the AI research hot spot can continue to expand. If the market reverts to traditional AI Agents, Layer 1, or PayFi directions, the attention on DeSci may weaken again.

Second, the pace of Bio Protocol’s product development.

Currently, BIO’s heat largely relies on recent updates like PeptAI, BioXP, and AI Scientist. If new products, collaborations, or research scenarios are continuously launched, BIO could maintain high discussion levels.

Additionally, overall market risk appetite is crucial. The recent revival of high-risk assets is partly related to overall market sentiment recovery. If the market shifts back to risk aversion, volatility pressures on small-cap AI assets could increase again.

Therefore, for BIO, what to watch is not just short-term price fluctuations but whether AI research concepts can gradually form a long-term market structure.

Summary

BIO’s recent rise essentially reflects the expansion of AI hotspots from traditional Agents and trading tools to AI research and DeSci directions. Compared to the previous phase of concept speculation, the current market is increasingly focused on whether AI can enter more genuine research and data collaboration scenarios.

Structurally, BIO’s core driving forces now mainly come from the spread of AI research hotspots, the re-rotation of the DeSci sector, and the return of high-risk capital. Meanwhile, Bio Protocol’s recent product development pace further enhances market discussion.

However, the market remains highly volatile, and short-term sentiment still has a significant impact on BIO.

In the next phase, what to watch is not just BIO’s short-term price movements but whether DeSci can truly develop sustained market demand and whether AI research will become an important entry point for the next wave of AI hotspot expansion.

FAQ

What are the main reasons for BIO’s recent rise?

BIO’s recent rise is mainly related to Bio Protocol’s continuous promotion of PeptAI, BioXP, and AI research-related developments. Additionally, the resurgence of AI research and DeSci concepts has also boosted market attention.

Why is AI research starting to attract attention in the crypto market?

AI research is gaining attention because the market is seeking new application directions for AI sectors. Compared to traditional AI Meme or Agent concepts, AI research is more conducive to forming long-term narratives.

Is BIO currently a long-term value play or a short-term hot spot?

Based on current market structure, BIO still leans toward a high-volatility hot asset, heavily influenced by short-term funds. Whether AI research can form long-term demand remains a key point to watch.

Why has DeSci sector become active again recently?

DeSci has become active again largely due to the spread of AI hotspots. As AI applications extend into research and data collaboration, the market has started to pay renewed attention to the DeSci sector.